OneDigital Investment Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
TWC
ACH
DCM
OneDigital Investment Advisors's ABCL Position: Q1 2026 in Review
OneDigital Investment Advisors increased its AbCellera Biologics (ABCL) stake by 42% in Q1 2026, buying an estimated $36K and bringing the position to 34,000 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.
OneDigital Investment Advisors first reported a position in ABCL in Q3 2025 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.
- OneDigital Investment Advisors held 34,000 shares of AbCellera Biologics worth $119K as of Q1 2026.
- OneDigital Investment Advisors bought 10,000 AbCellera Biologics shares in Q1 2026, an estimated $36K.
- AbCellera Biologics made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #1420 holding.
- OneDigital Investment Advisors first reported a position in AbCellera Biologics in Q3 2025 and has held it in 3 quarters since.
- 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.
Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.